|
|
|
Volumn 16, Issue 5, 2003, Pages 270-272
|
|
Misunderstanding depression
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIDEPRESSANT AGENT;
BENZODIAZEPINE;
CITALOPRAM;
FLUOXETINE;
FLUVOXAMINE;
MIRTAZAPINE;
PAROXETINE;
REBOXETINE;
SEROTONIN UPTAKE INHIBITOR;
SERTRALINE;
TRICYCLIC ANTIDEPRESSANT AGENT;
VENLAFAXINE;
ANTICHOLINERGIC EFFECT;
CLINICAL TRIAL;
COPING BEHAVIOR;
DEPRESSION;
DISEASE CLASSIFICATION;
DOSE RESPONSE;
DRUG COST;
DRUG DEPENDENCE;
DRUG METABOLISM;
DYSTHYMIA;
ELECTROCONVULSIVE THERAPY;
EMOTIONAL STRESS;
ENDOGENOUS DEPRESSION;
EVIDENCE BASED MEDICINE;
HUMAN;
MAJOR DEPRESSION;
MEDICAL RESEARCH;
MENTAL STRESS;
NOTE;
PRIMARY MEDICAL CARE;
PSYCHOTHERAPY;
REACTIVE DEPRESSION;
RESIDENCY EDUCATION;
SEDATION;
SIDE EFFECT;
ANTIDEPRESSIVE AGENTS;
ATTITUDE OF HEALTH PERSONNEL;
DEPRESSION;
DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS;
HUMANS;
PHYSICIAN'S PRACTICE PATTERNS;
PRIMARY HEALTH CARE;
RISK REDUCTION BEHAVIOR;
|
|
EID: 0344739997
PISSN: 0970258X
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
|
Times cited : (6)
|
|
References (0)
|
